...

Johnson vs Monsanto: The Roundup Lawsuit

by Fadi Agour | Apr 8, 2019

roundup lawsuit

Did you know that an estimated 1.4 billion pounds of Roundup herbicide are used every year worldwide?

This is a shocking number, considering that this weed killer has been associated with numerous deadly conditions, including many forms of cancer.

Moreover, the International Agency for Research on Cancer (IARC), a branch of the WHO, has classified this herbicide commonly used on many crops as “probably carcinogenic.”

The Roundup Lawsuit has allowed for the voices of those potentially impacted to call for action, and to shine a light on exactly what the science says about this so-called “harmless weed killer.”

Read on to learn more about what this lawsuit could mean for those suffering, and for the country as a whole.

The Roundup Lawsuit: Five Things to Know

While there is plenty of science that can be beneficial to learn about when speaking about Roundup, there are also a few key facts you will need to know about the lawsuit in particular.

Here are five things to keep in mind if you are lawyer interested in getting involved in this lawsuit, or if you or a loved one have felt the effects of this chemical.

1. What Is Roundup?

First and foremost, you should know that the herbicide that is commonly known as “Roundup Weed Killer” is scientifically known as “Glycophosphate.”

This chemical was invented in 1970, by researchers at Monsanto, a large agriculture company that is heavily involved in the GMO industry.

Glycophosphate kills unwanted weeds and grasses with incredible efficiency. Then, by using genetically modified seeds and crops that are resilient to it, Monsanto has become an unstoppable machine.

2. Why Was This Lawsuit Filed?

There are thousands of current lawsuits filed with Monsanto regarding Glycophosphate. Due to the volume of them, the federal multidistrict litigation has consolidated them into MDL No. 2741 in California.

Under this litigation, there are about 624 lawsuits filed. Each individual will receive a trial, and the MDL reflects a more unified pretrial phase.

3. What Were the Health Risks?

The health risks that have been associated with Roundup include several types of Lymphoma and Leukemia.

A recent review of the European Union’s (EU) and IARC findings on this chemical stated that the latter found some evidence of “receptor-mediated effects, cell proliferation or death, and immune effects.”

Therefore, it is not fully known yet what effects the chemical based on real-world exposures in people. But cancer and other conditions involving the immune system are possible.

The Environmental Protection Agency is currently undergoing its own review.

4. Was There Collusion?

In one of the trials that have taken place, plaintiffs accused Monsanto/Bayer of ghostwriting its own cancer studies and parts of scientific reports and provided incriminating evidence of them doing so.

Though the company vehemently denies these accusations of bias evidence that the EPA used to determine the chemical’s safety, the truth is up in the air.

5. Why Should You Find the Right Plaintiffs?

Considering the current evidence, there are plenty of reasons for U.S. attorneys to seek those impacted by Monsanto. Even if these cases do not go to court, the Roundup lawsuit payout will likely be tremendous.

In both cases that have gone to trial thus far, the plaintiffs have received millions of dollars for their healthcare costs, lost income, and pain and suffering.

Final Thoughts: Generate Leads for the Roundup Court Case

All and all, it is in your best interest as an attorney to stay up-to-date on the latest trials unfolding nationwide and to seek potential plaintiffs for this lawsuit.

Through our process of strategizing, effectively targeting, and executing, we can continually optimize the quality of leads you get for your law firm.

Ready to get started? Contact us for more information on how to find the right clients for the Roundup Lawsuit.

Explore More Articles

Bicycle Crash Claims: What Personal Injury Firms Need to Know About Liability, Evidence, and Intake

In 2024, 1,103 cyclists were killed and an estimated 52,887 were injured in U.S. traffic crashes, according to the National Highway Traffic Safety Administration. For plaintiff firms, those crashes produce some of the most serious injuries in the motor vehicle docket...

The Jealous Mistress Was Always a Bad Business Model: A Growth Framework for Solo and Small Personal Injury Firms

The Jealous Mistress Was Always a Bad Business Model: A Growth Framework for Solo and Small Personal Injury Firms Justice Story's line about the law demanding "lavish homage" has been quoted to every law student for two centuries. It produced a profession with...

Nearly Half of Law Firms Cannot Be Reached by Phone. The Problem Is Not Marketing. It Is the Empty Chair Next to the Owner.

In 2024, Clio commissioned a secret-shopper study of American law firms. Researchers posed as prospective clients and contacted 500 firms by phone and email. The results, published in the 2024 Legal Trends Report, were unambiguous. Only 40 percent of firms answered...

The Trial Lawyer Who Never Tries a Case: How to Grow a Personal Injury Firm Without Losing the Only Leverage That Matters

In 1990, federal district courts completed 4,765 civil jury trials. In 2025, according to the Administrative Office of the U.S. Courts, they completed 1,048, a decline of 10 percent in a single year and roughly 78 percent over the generation. The state courts, where...

Best Case Leads Celebrates Sixth Consecutive Year on Inc. 5000 List of Fastest-Growing Private Companies in America

Aug 19, 2025 | Press Releases Houston, TX, August 18, 2025 — Best Case Leads, a pioneering leader in legal lead generation, proudly announces its sixth consecutive recognition on the prestigious Inc. 5000 fastest-growing private companies in America, securing...

Baby Formula Litigation, NEC Claims, and the Evolving Landscape of Mass Torts

By Fadi Agour, J.D. Families of premature infants who developed necrotizing enterocolitis (NEC) after being fed cow–milk–based formula products like Similac and Enfamil continue to pursue justice in both state and federal courts. Recent...

Mass Tort Landscape 2025: Key Cases, Trends & Strategic Opportunities

The mass tort landscape is evolving rapidly, with new cases gaining momentum and established litigations reaching critical phases. For law firms and legal marketers, timing is everything—success hinges on anticipating trends, securing high-value claimants early, and...

Zyprexa & Risperdal 2: The Breast Cancer Link That Could Ignite the Next Mass Tort

The pharmaceutical litigation landscape has seen its share of blockbuster cases—from opioid multidistrict litigations to the ongoing Paraquat Parkinson’s claims. But a new California lawsuit (Brown v. Johnson & Johnson et al.) could revive two legacy antipsychotics...

Mass Torts in 2025: A Legal Landscape in Flux

As 2025 unfolds, the world of mass tort litigation shows no signs of slowing down. From pharmaceutical giants to tech behemoths, corporations across industries are facing an unprecedented wave of lawsuits that could reshape their futures. With judges issuing critical...

The PFAS Contamination Crisis: A Deep Dive into the Mass Tort Litigation and Its Implications

Per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” have become a focal point of environmental and public health concerns in the United States. These synthetic chemicals, used for their water, heat, and grease-resistant properties,...